ATRA vs BXP · rev $128.9M vs rev $3.48B
Atara Biotherapeutics Inc (ATRA) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
ATRA currently screens at market cap $87.1M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the ATRA and BXP stock pages for the full models.
Not investment advice.